Evidence map›Paper›PMID 32978261›Full record

ArticleThe Journal of biological chemistry2020

ERAD deficiency promotes mitochondrial dysfunction and transcriptional rewiring in human hepatic cells.

Qingqing Liu, Xiaoqin Yang, Guangyu Long, Yabing Hu, Zhenglong Gu, Yves R Boisclair, Qiaoming Long

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. World journal of gastroenterology · 2025
    Article
  4. Article
  5. Review
  6. Establishment of aJournal of pathogens · 2024
    Article
  7. SEL1L preserves CD8Cellular & molecular immunology · 2023
    Article
  8. Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review).International journal of molecular medicine · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Qingqing LiuJiangsu Key Laboratory of Neuropsychiatric Diseases and Cam-Su Mouse Genomic Resources Center, Medical College of Soochow University, Suzhou, Jiangsu Province, China.
Xiaoqin YangJiangsu Key Laboratory of Neuropsychiatric Diseases and Cam-Su Mouse Genomic Resources Center, Medical College of Soochow University, Suzhou, Jiangsu Province, China.
Guangyu LongJiangsu Key Laboratory of Neuropsychiatric Diseases and Cam-Su Mouse Genomic Resources Center, Medical College of Soochow University, Suzhou, Jiangsu Province, China.
Yabing HuJiangsu Key Laboratory of Neuropsychiatric Diseases and Cam-Su Mouse Genomic Resources Center, Medical College of Soochow University, Suzhou, Jiangsu Province, China.
Zhenglong GuDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA.
Yves R BoisclairDepartment of Animal Science, Cornell University, College of Agriculture and Life Sciences, Ithaca, New York, USA.
Qiaoming LongJiangsu Key Laboratory of Neuropsychiatric Diseases and Cam-Su Mouse Genomic Resources Center, Medical College of Soochow University, Suzhou, Jiangsu Province, China. Electronic address: qmlong@suda.edu.cn.
Soochow University · CNCornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial dysfunction is associated with a variety of human diseases including neurodegeneration, diabetes, nonalcohol fatty liver disease (NAFLD), and cancer, but its underlying causes are incompletely understood. Using the human hepatic cell line HepG2 as a model, we show here that endoplasmic reticulum-associated degradation (ERAD), an ER protein quality control process, is critically required for mitochondrial function in mammalian cells. Pharmacological inhibition or genetic ablation of key proteins involved in ERAD increased cell death under both basal conditions and in response to proinflammatory cytokines, a situation frequently found in NAFLD. Decreased viability of ERAD-deficient HepG2 cells was traced to impaired mitochondrial functions including reduced ATP production, enhanced reactive oxygen species (ROS) accumulation, and increased mitochondrial outer membrane permeability. Transcriptome profiling revealed widespread down-regulation of genes underpinning mitochondrial functions, and up-regulation of genes associated with tumor growth and aggression. These results highlight a critical role for ERAD in maintaining mitochondrial functional and structural integrity and raise the possibility of improving cellular and organismal mitochondrial function via enhancing cellular ERAD capacity.

Indexed as

TranscriptomeAdenosine TriphosphateApoptosisCell SurvivalDown-RegulationEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationGene EditingHep G2 CellsHumansInterleukin-12Membrane Potential, MitochondrialMitochondriaProteinsReactive Oxygen SpeciesTumor Necrosis Factor-alphaAdenosine TriphosphateInterleukin-12ProteinsReactive Oxygen SpeciesSEL1L protein, humanTumor Necrosis Factor-alphacalciumcell deathcytochrome cendoplasmic reticulumendoplasmic reticulum-associated protein degradation (ERAD)endoplasmic reticulum stress (ER stress)ERADhepatocyte deathlivermitochondriamitochondrial diseasemitochondrial permeability transition (MPT)ROSSEL1L

Identifiers

PMID32978261
PMCPMC7864069
OpenAlexW3088909390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.